Mannan Oligosaccharide Market Size, Share, and Growth Forecast, 2026 – 2033

The global mannan oligosaccharide market size is likely to be valued at US$1.2 billion in 2026 and is expected to reach US$2.1 billion by 2033, growing at a CAGR of 8.3% during the forecast period from 2026 to 2033.

Rising awareness regarding gut health and immune modulation is driving the widespread adoption of these prebiotics. Technology advancements in seaweed extraction methods enhance supply efficiency across feed applications. Structural shifts toward gut health in human nutrition broaden addressable segments beyond traditional livestock uses.

Market expansion remains anchored in the structural shift toward antibiotic-free animal production and functional human nutrition. This transition is projected to sustain long-term demand across diversified end-user segments.

• Leading Region: North America is projected to lead, accounting for approximately 36% share in 2026, supported by established pet food manufacturing and strict livestock regulations.
• Fastest-growing Region: Asia Pacific is anticipated to grow fastest, driven by rapid aquaculture expansion and increasing pharmaceutical investments.
• Leading Product Type: Powder is expected to lead, accounting for approximately 82% share in 2026, anchored by high stability and ease of bulk mixing.
• Leading Source: Yeast is anticipated to dominate, accounting for approximately 74% share in 2026, anchored by established Saccharomyces cerevisiae extraction processes, proven efficacy data, and scalable production economics.

Driver Analysis – Regulatory Restrictions Accelerating Adoption of Yeast-Derived Feed Additives

Stringent regulatory controls on antibiotic growth promoters are reshaping livestock feed formulation strategies globally. Legislative interventions targeting antimicrobial resistance directly restrict the routine inclusion of synthetic growth stimulants. This regulatory pressure compels producers to transition toward biologically derived feed additives with functional health benefits. Maintaining intestinal integrity becomes critical for sustaining feed conversion efficiency under antibiotic-free production systems. Yeast-derived prebiotics offer microbial modulation capabilities that stabilize gut ecosystems without pharmacological intervention. Consequently, feed manufacturers increasingly integrate these bioactive compounds to align with compliance mandates. This cause–and–effect dynamic structurally expands demand for non-antibiotic performance enhancers across intensive livestock operations.

Commercial adoption is reinforced by product innovations that align functional efficacy with regulatory compliance requirements. Alltech with Bio-Mos 2 utilizes yeast cell wall fractions to enhance pathogen exclusion mechanisms. Phileo by Lesaffre with Safmannan delivers targeted pathogen-binding functionality through refined mannan-rich fractions. These technologies enable producers to maintain productivity metrics while adhering to antimicrobial reduction frameworks. Improved gut health directly supports nutrient absorption efficiency, influencing overall protein yield and growth consistency. Cost structures are optimized through reduced disease incidence and lower dependency on therapeutic interventions. Collectively, these advancements institutionalize yeast-derived additives as critical components within modern feed systems.

Expansion of Human Gut Health Formulations Using Mannan-Based Prebiotics

Heightened consumer awareness of microbiome health is accelerating demand for functional prebiotic supplementation formats. Dietary patterns characterized by low fiber intake and elevated stress contribute to widespread dysbiosis conditions. This imbalance necessitates targeted incorporation of mannan-oligosaccharides within daily nutritional regimens for gut stability. Supplement manufacturers increasingly integrate MOS to complement probiotic strains and enhance microbial diversity outcomes. Clinical validation linking prebiotics to immune modulation strengthens their inclusion within preventative healthcare frameworks. Regulatory acceptance of structure-function claims further supports commercialization across nutraceutical and functional food categories. These converging factors structurally expand formulation demand for microbiome-supportive ingredients.

Product innovation and clean-label positioning reinforce competitive differentiation within the expanding gut health supplementation landscape. DSM Nutritional Products with DelvoMOS enables versatile incorporation across capsules and powdered delivery systems. Ohly GmbH with Ohly MOS aligns with clean-label certification standards that influence purchasing decisions among informed consumers. DuPont, with Sensus advances refined prebiotic fiber solutions that enhance mineral absorption and bacterial proliferation efficiency. Biorigin with HiCell supports ingredient transparency while maintaining functional performance across diverse applications. Expanded retail distribution channels increase product visibility and accessibility within wellness-oriented consumer segments.

Restraint Analysis – Extraction Process Cost Premiums Limiting Commercial Scalability

Advanced enzymatic extraction technologies improve MOS purity but introduce elevated processing overheads across production systems. These methods require specialized catalysts, controlled reaction environments, and stringent downstream purification infrastructure investments. Capital intensity and operational expenditures increase relative to conventional hydrolysis-based extraction methodologies used historically. This cost differential constrains competitive pricing strategies within highly price-sensitive livestock and aquaculture feed segments. Formulators must balance functional efficacy gains against strict feed cost thresholds governing large-scale procurement decisions. Consequently, adoption remains uneven where incremental performance benefits do not justify elevated inclusion costs.

Market participants attempt to segment applications based on value realization potential and end-use economic tolerance levels. CP Kelco with Kelcogel MOS strategically absorbs higher production costs to serve pharmaceutical-grade applications requiring purity assurance. Lewant Polyaccharides with SeaMOS Liquid encounter resistance within bulk aquaculture feeds due to constrained cost absorption capacity. Scale economies remain limited as demand fragmentation prevents uniform production expansion across application categories. Cost structures, therefore, inhibit widespread diffusion despite demonstrated functional advantages in gut health optimization. These dynamics collectively slow commercialization until process efficiencies align with broader market affordability thresholds.

Raw Material Price Volatility Impacting Prebiotic Production Economics

Fluctuating costs of yeast derivatives and botanical substrates exert sustained pressure on prebiotic manufacturing economics. Agricultural commodity price variability directly influences input procurement expenses across fermentation and extraction processes. Supply chain disruptions further exacerbate inconsistencies in the availability of high-quality raw material inputs globally. These cost instabilities compress operating margins, particularly within price-sensitive livestock and nutraceutical application segments. Manufacturers must continuously recalibrate sourcing strategies to manage exposure to volatile upstream market conditions. Elevated input costs ultimately constrain pricing flexibility and limit the broader affordability of advanced prebiotic formulations.

Operational responses increasingly emphasize efficiency optimization and supply chain integration to mitigate financial exposure risks. Titan Biotech with MOS Powder enhances extraction yield efficiency to maximize output from constrained raw inputs. This process-level optimization reduces unit production costs despite fluctuations in substrate pricing environments. Kemin, with VANNOMOS, leverages vertically integrated sourcing structures to stabilize supply continuity and cost predictability. Such integration minimizes dependency on external suppliers and buffers against abrupt commodity price escalations. Inventory management practices become critical in balancing procurement timing with production planning requirements. Collectively, these measures partially offset volatility but do not eliminate structural cost pressures.

Opportunity Analysis – Seaweed-Derived Ingredient Innovation Expanding Sustainable Prebiotic Sources

Sustainable sourcing from marine biomass is redefining input strategies within the prebiotic ingredient manufacturing landscape. Seaweed offers a renewable substrate with high polysaccharide density, supporting efficient extraction of functional compounds. This diversification reduces dependence on terrestrial yeast inputs, mitigating supply concentration risks and agricultural volatility exposure. Environmental regulations and sustainability reporting frameworks incentivize the adoption of low-impact raw material sourcing alternatives. Advanced extraction technologies enable the isolation of high-purity bioactive fractions suitable for nutraceutical and feed applications. These process innovations align cost structures with environmental compliance, strengthening the commercial viability of marine-derived ingredients.

Industrial players are integrating marine substrates to enhance product differentiation and sustainability positioning across applications. Phileo by Lesaffre with Safmannan is evaluating algae-based fractions to strengthen environmental performance metrics. Lallemand with OPTIWALL leverages alternative substrates to develop distinct prebiotic functionalities targeting diverse microbiome responses. These innovations align with the aquaculture sector requirements for sustainable feed inputs and reduced ecological impact. Consumer preference for ocean-derived ingredients further supports market acceptance across wellness and nutrition segments. Supply chain adaptation toward marine sourcing introduces new operational models and procurement frameworks. Collectively, these dynamics expand high-value niche opportunities within environmentally aligned prebiotic markets.

Cosmetics Active Stabilization Using Mannan-Based Prebiotic Ingredients

Skin care formulation science increasingly incorporates MOS to support barrier repair and hydration retention mechanisms. These bioactive compounds interact with skin microbiota, reinforcing protective functions and reducing transepidermal water loss. Stable powder formats enable compatibility with cold-process emulsions, minimizing thermal degradation risks during manufacturing. This stability reduces reliance on preservative systems that may conflict with sensitive skin formulations. Regulatory scrutiny over cosmetic ingredients further encourages the adoption of microbiome-friendly actives with proven safety profiles. Consequently, MOS integration aligns functional efficacy with evolving compliance and formulation constraints within advanced skincare systems.

Innovation pipelines emphasize delivery optimization and formulation versatility to maximize functional performance across product formats. Ohly GmbH with Ohly MOS evaluates dispersion behavior within complex oil-water emulsion systems for stability assurance. Biorigin with Biorigin MOS advances encapsulation techniques, enabling controlled release and sustained bioactivity on skin surfaces. These technological approaches enhance ingredient compatibility across serums, creams, and hybrid cosmetic formulations. Brand collaborations increasingly target prestige segments seeking scientifically differentiated and performance-driven actives. Cost structures are influenced by encapsulation and stabilization technologies, shaping pricing within premium skincare categories. Collectively, these developments expand MOS applications within high-value cosmetic formulations.

Product Type Insights

Powder is anticipated to dominate, accounting for approximately 82% share in 2026, reinforced by superior shelf-life and handling characteristics. Bulk feed manufacturing processes prioritize dry formats for seamless integration into existing mixing workflows. Stability under high-temperature pelleting ensures that bioactive properties remain intact during processing. Manufacturers prefer powdered additives due to lower transportation costs relative to liquid counterparts. This logistical advantage sustains wide-scale adoption across large agricultural operations. Alltech with Bio-Mos 2 demonstrates high compatibility with standard milling equipment. Titan Biotech with MOS Powder reinforces this standard through optimized particle size distribution. Consistent performance across diverse climates further bolsters the segment's market position.

Liquid is forecast to be the fastest-growing segment, driven by increasing adoption in precise drinking water delivery systems. This format allows for immediate health intervention during periods of high animal stress. Liquid prebiotics provide higher solubility, which is essential for modern automated hydration lines. Intensive farming operations utilize these solutions to ensure rapid nutrient uptake among young stock. Phileo by Lesaffre with Safmannan in liquid form offers flexibility for on-farm mixing requirements. Kemin with VANNOMOS liquid formulations addresses the need for agile health management in aquaculture. As precision farming gains momentum, demand for injectable or water-soluble additives is poised to rise.

Source Insights

Yeast is anticipated to dominate, accounting for approximately 74% share in 2026, underpinned by established extraction protocols and high efficacy. The cell walls of Saccharomyces cerevisiae serve as the primary reservoir for functional mannans. This source provides a consistent bioactive profile that is well-documented in scientific literature. Large-scale fermentation industries ensure a steady supply of raw materials for manufacturers. Lallemand, with OPTIWALL, utilizes specialized yeast strains to maximize prebiotic yield during production. Biorigin with HiCell leverages this traditional source to deliver high-purity ingredients for human health. This structural dominance remains anchored in the reliability and scalability of yeast-based fermentation.

Seaweed, also called algae-derived Mos, is expected to be the fastest-growing segment, driven by the structural pivot toward sustainable and clean-label sourcing. Marine environments offer unique polysaccharide structures that provide differentiated health benefits. These novel substrates align with consumer demand for renewable and environmentally friendly products. Advanced biorefinery technologies are enabling more efficient recovery of mannans from diverse seaweed species. Phileo by Lesaffre with Safmannan is exploring these marine alternatives to expand its functional portfolio. DuPont with Sensus is positioned to incorporate algae-based fibers into premium nutritional offerings. This transition toward ocean-based resources reflects a broader industrial commitment to ecological stewardship.

North America Mannan Oligosaccharide Market Trends

North America is expected to remain the leading regional market, accounting for approximately 36% share in 2026, supported by high pet ownership rates and advanced livestock production systems. The region's market depth is anchored in the early adoption of functional ingredients across both animal and human nutrition sectors. Strict regulatory oversight regarding antibiotic use in agriculture has pushed producers toward biological alternatives. Large-scale pet food manufacturers prioritize premium prebiotic additives to meet the demands of health-conscious owners. This structural maturity is reinforced by a robust network of ingredient suppliers and research institutions.

The U.S. is expected to anchor regional momentum through sustained investments in automated animal health solutions. High per capita spending on companion animals drives the inclusion of advanced prebiotics in premium pet diets. Cargill with Provimi is expanding its domestic production capacity to meet this rising demand. Regulatory pressure from the FDA regarding feed safety is projected to increase procurement of traceable ingredients. This environment fosters a competitive landscape where technical efficacy and transparency are essential for success.

Asia Pacific Mannan Oligosaccharide Market Trends

Asia Pacific is expected to register the fastest growth trajectory, as massive infrastructure buildout and expanding aquaculture operations accelerate market expansion. The region's rapid development is driven by the modernization of agricultural practices in high-population economies. Increasing disposable income levels are fueling a transition toward protein-rich diets and premium nutritional products. Government initiatives promoting food security and sustainable farming are encouraging the use of functional additives. This dynamic environment is attracting significant global investment from leading prebiotic manufacturers seeking to scale.

China is anticipated to lead regional acceleration through the large-scale industrialization of its livestock and fish farming sectors. National policies aiming to reduce chemical residues in food are compelling producers to adopt natural prebiotics. Alltech with Bio-Mos 2 is gaining ground as local farmers seek to improve feed conversion ratios. Rising awareness of gut health among urban consumers is also boosting the dietary supplement industry. This focus on efficiency and quality is poised to drive record procurement volumes.

Europe Mannan Oligosaccharide Market Trends

Europe is expected to remain a mature and structurally stable regional market, with demand primarily anchored in replacement cycles and strict compliance upgrades. The European Commission's early ban on antibiotic growth promoters has created a deeply embedded market for natural additives. Manufacturers in this region focus on premiumization and high-purity formulations to differentiate their products. Demand is sustained by a well-informed consumer base that prioritizes animal welfare and environmental sustainability. This region serves as a benchmark for regulatory standards and innovation in functional fibers.

France is forecast to remain a central hub for prebiotic innovation due to its strong fermentation and dairy industries. Local companies are leading the way in developing specialized yeast-based solutions for global export. Phileo by Lesaffre with Safmannan exemplifies the French expertise in microbial solutions for animal nutrition. Ongoing research into sustainable sourcing is expected to strengthen the country's influence on regional trends. High adherence to organic farming standards continues to support the uptake of certified prebiotic ingredients.

The global mannan oligosaccharide market exhibits a moderately consolidated structure, where a group of established multinational entities exerts significant functional influence. These market leaders maintain their positions through extensive technology footprints and deep-rooted procurement relationships across the value chain. Brand equity remains a critical differentiator as manufacturers prioritize reliability and scientific validation in their marketing efforts. Smaller, niche participants often compete by focusing on specialized applications or innovative sourcing methods like seaweed extraction. This concentration of expertise allows for sustained investment in research and global distribution networks.

Competitive positioning is increasingly defined by horizontal differentiation through expanded product portfolios and multi-tier pricing strategies. Premium players emphasize clinical efficacy and traceability to capture high-margin segments in human nutrition and pet food. Conversely, value-oriented vendors focus on operational efficiency to provide cost-effective solutions for large-scale livestock operations. Competitive intensity is likely to heighten as firms integrate digital tools for better supply chain visibility and performance tracking.

Key Industry Developments:

• In January 2026, Alltech integrated AI-driven predictive modeling into its Global Harvest Analysis to help producers optimize MOS inclusion rates. Leveraging AI allows farmers to proactively use MOS as a biological safeguard against fluctuating feed quality risks, reinforcing MOS as a "must-have" rather than an "optional" additive.
• In October 2025, Lallemand Animal Nutrition launched a global educational program focused on Ruminant Digestive Welfare. By educating veterinarians and nutritionists on the biological role of MOS in rumen health, the company is effectively building a "consultative" sales pipeline to drive long-term market share.